Biotech · Private company · Silver Spring, MD, US
Autonomous Therapeutics, Inc.
Track this companyFree. Adds Autonomous Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards8
- Targeting Feedback Circuitry for Antiviral TherapyFiscal year 2026 · $1.5MNIH RePORTER 5R01AI180651-03 · fetched Nov 12, 2026
- AT191: An inhaled & precision RNA therapeutic with pan-variant SARS-CoV-2 efficacyFiscal year 2026 · $976.6KNIH RePORTER 5R44AI186871-02 · fetched Nov 12, 2026
- AT191: An inhaled & precision RNA therapeutic with pan-variant SARS-CoV-2 efficacyFiscal year 2025 · $1MNIH RePORTER 1R44AI186871-01A1 · fetched Nov 12, 2026
- Modulating Stochastic Gene Expression for Cell-fate Control and TherapeuticsFiscal year 2025 · $1.9MNIH RePORTER 5R37AI109593-11 · fetched Nov 12, 2026
- Targeting Feedback Circuitry for Antiviral TherapyFiscal year 2025 · $1.5MNIH RePORTER 7R01AI180651-02 · fetched Nov 12, 2026
- Synthetic RNA sensors to enable high-throughput, quantitative screens for broad-spectrum antiviralsFiscal year 2024 · $273.6KNIH RePORTER 1R43AI184267-01 · fetched Nov 12, 2026
- A Gene Drive Therapy for HIV: Single-Administration Intervention for High-RiskGroupsFiscal year 2024 · $716.8KNIH RePORTER 7DP1DA051144-06 · fetched Nov 12, 2026
- Modulating Stochastic Gene Expression for Cell-fate Control and TherapeuticsFiscal year 2024 · $905.9KNIH RePORTER 7R37AI109593-10 · fetched Nov 12, 2026